Abstract:Background & Aims: The therapeutic activity of bone marrow mesenchymal stem cells (MSCs) in a rat model of acute hepatocyte injury through polarizing M2 macrophages, but the molecular pathway of MSCs inducing macrophages M2 polarization in acute hepatocyte injury is unknown. We investigate the molecular pathway of MSCs inducing polarizing M2 macrophages and described the potential therapy of MSC-induced M2 macrophages in acute hepatocyte injury. Methods: Co-culture of Rat hepatic macrophages(M0) and MSCs, the expression levels of M2 polarized markers (CD163, TGF-β, Arg-1) were detected by RT-PCR to confirm the MSC-induced macrophages M2 polarization in vitro. The location of GFP-labeled MSCs and IL-4 was expressed by immunofluorescence. The proteomic profiling to assess the survival and death groups after MSCs transplantation to analysis potential molecular pathway of macrophages M2 polarization. The macrophages M2 polarization marker including IL-4, CD163, TGF-β, IL-10 and Arg1 were detected by Western Blot, RT-PCR and ELISA. The expression levels of ALT and AST were measured in injured hepatocytes supernatant co-cultured with M2 macrophages by ELISA. Results: The expression level of M2 macrophages polarizing markers (CD163, TGF-β, Arg-1) were significantly increased after macrophages co-culture with MSCs in vitro. MSC transplanted into the body are co-expressed with IL-4 by immunofluorescence and liver proteomic analysis identified STAT6 protein involved in the survival and death after MSCs treatment in a rat acute liver failure model. MSC-induced macrophages M2 polarization activated STAT6 protein expression by IL-4. STAT6 inhibitors significantly inhibited the expression of macrophages M2 polarization markers (IL-4, CD163, TGF-β, IL-10 and Arg1). Co-culture of M2 macrophages and injured hepatocytes significantly reduced the secretion of ALT and AST from hepatocytes. Conclusions: MSCs induce macrophages M2 phenotype polarization by activating STAT6, and M2 macrophages increased expression of anti-inflammatory factors(IL-4, CD163, TGF-β, IL-10 and Arg1) and ameliorated acute hepatocyte injury.Funding Statement: This work funded by “Thirteenth Five-Year Plan” Major National Science and technology major projects (2017ZX10201201, 2017ZX10202202); Liaoning Provincial Local Professional Technology Innovation Platform Construction Project (2016007013); Liaoning Provincial Natural Science Foundation 2014021007); Outstanding Scientific Fund of Shengjing Hospital (2011-02).Declaration of Interests: The authors declare that there is no duality of interest associated with this manuscript.Ethics Approval Statement: All procedures involving animals were reviewed and approved by the Institutional Animal Care and Use Committee of the Ethics Committee of Shengjing Hospital of China Medical University Institutional. (IACUC protocol number: 2016PS248K)

Mesenchymal Stem Cell Repair Acute Hepatocyte Injury Through Inducing Macrophages M2 Polarization Via STAT6

Mouse Bone Marrow-Derived Mesenchymal Stem Cells Induce Macrophage M2 Polarization Through the Nuclear Factor-Κb and Signal Transducer and Activator of Transcription 3 Pathways

Mesenchymal stem cell treatment restores liver macrophages homeostasis to alleviate mouse acute liver injury revealed by single-cell analysis.

Nutrition and Acne: Therapeutic Potential of Ketogenic Diets

Mesenchymal stem cells promote polarization of M2 macrophages in mice with acute-on-chronic liver failure via Mertk/JAK1/STAT6 signaling

Mesenchymal Stem Cells Secreted-Prostaglandin E2 Ameliorates Acute Liver Failure Via Attenuation Cell Death and Regulation of Macrophage Polarization

Correction: Mesenchymal stem cell-secreted prostaglandin E2 ameliorates acute liver failure via attenuation of cell death and regulation of macrophage polarization

Mesenchymal stem cell-secreted prostaglandin E2 ameliorates acute liver failure via attenuation of cell death and regulation of macrophage polarization

Transplantation of Mesenchymal Stem Cells Attenuates Acute Liver Failure in Mice Via an Interleukin-4-dependent Switch to the M2 Macrophage Anti-inflammatory Phenotype

Mesenchymal stem cells derived exosomes ameliorate D-galN/LPS induced acute liver injury via PTEN-mediated macrophage polarization

Abstract PR566

Mesenchymal stem cells attenuate liver fibrosis by targeting Ly6Chi/lo macrophages through activating the cytokine-paracrine and apoptotic pathways

Placental mesenchymal stem cells suppress inflammation and promote M2-like macrophage polarization through the IL-10/STAT3/NLRP3 axis in acute lung injury

The Effects of Conditioned Medium Derived from Mesenchymal Stem Cells Cocultured with Hepatocytes on Damaged Hepatocytes and Acute Liver Failure in Rats

Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration

Therapeutic Effect and Mechanism of Mesenchymal Stem Cells on Acute Liver Failure

Improvement of mesenchymal stromal cells and their derivatives for treating acute liver failure

SDF-1/CXCR4 Augments the Therapeutic Effect of Bone Marrow Mesenchymal Stem Cells in the Treatment of Lipopolysaccharide-Induced Liver Injury by Promoting Their Migration Through PI3K/Akt Signaling Pathway

Mesenchymal Stem Cells Alleviate Acute Liver Failure through Regulating Hepatocyte Apoptosis and Macrophage Polarization

Placental chorionic plate-derived mesenchymal stem cells ameliorate severe acute pancreatitis by regulating macrophage polarization via secreting TSG-6

Mesenchymal stem cells ameliorate rhabdomyolysis-induced acute kidney injury via the activation of M2 macrophages